NASA Hosts Workshop to Discuss Asteroid Initiative Ideas

Posted on by

NASA will host a public workshop to examine and synthesize 96 of the ideas submitted to a Request for Information (RFI) about the agency's asteroid initiative. The workshop will be held Sept. 30 - Oct. 2 at the Lunar and Planetary Institute in Houston.

The workshop will feature discussions by experts from NASA, the agency's international partners, private industry and the public. Topics include how best to identify, capture and relocate a near-Earth asteroid for closer study, how to respond to asteroid threats, as well as partnership, crowdsourcing and citizen science ideas. Workshop results will be considered for future planning as NASA refines the details of its mission.

NASA's fiscal year 2014 budget proposes an asteroid initiative that includes a strategy to leverage human and robotic activities for a first-ever human mission to an asteroid, while also accelerating efforts to improve detection and characterization of asteroids. The work aligns the agency's ongoing efforts in science, new technology development and human exploration.

NASA received more than 400 ideas in response to the June RFI. The ideas were submitted by industry, universities, international organizations, and for the first time, individual members of the public. NASA's selection process involved agency scientists, engineers and mission planners who are formulating details of the asteroid initiative.

Each session will be webcast on NASAs UStream channel, and virtual participation is encouraged. Because of limited capacity, in-person attendance is limited to invited, registered presenters. Selected sessions also will be broadcast on NASA Television. Virtual audience members can ask questions through the UStream chat function and via Twitter with session-specific hashtags. Complete schedule information, live webcasts, hashtags, and other details on how to participate virtually can be found at: http://go.nasa.gov/1gW1MId

Media interested in attending the workshop in person should contact Rachel Kraft at rachel.h.kraft@nasa.gov or Sarah Ramsey at sarah.ramsey@nasa.gov.

For NASA TV streaming video, downlink and scheduling information, visit: http://www.nasa.gov/ntv

For more information on NASA's asteroid initiative, visit: http://www.nasa.gov/asteroidinitiative

Please follow SpaceRef on Twitter and Like us on Facebook.

Read this article:

NASA Hosts Workshop to Discuss Asteroid Initiative Ideas

NASA Sees Typhoon Pabuk's Veiled Eye

Posted on by

The MODIS instrument aboard NASA's Aqua satellite captured this image of Typhoon Pabuk on Sept. 24 at 04:05 UTC as it was nearing Japan. High clouds drape over Pabuk's eye.Image Credit: NASA Goddard MODIS Rapid Response Team.

NASA's Aqua satellite orbit around the Earth took it right over Typhoon Pabuk and the image showed an eye veiled with some high clouds.

The Moderate Resolution Imaging Spectroradiometer or MODIS instrument that flies aboard NASA's Aqua satellite captured a visible image of Typhoon Pabuk on Sept. 24 at 04:05 UTC as it was nearing Japan. In the image, high clouds draped over Pabuk's eye. Pabuk's eye is about 30 nautical miles/34.5 miles/55.5 km wide, about three times larger than Typhoon Usagi's eye before it made landfall in China earlier in the week.

On Tuesday, Sept. 24 at 0900 UTC/5 a.m. EDT, Pabuk's maximum sustained winds were near 65 knots/75 mph/120.4 kph and some slight strengthening is expected. Pabuk's center was located near 26.4 north and 139.2 east, about 552 nautical miles/ 635.2 miles/1,022 km south of Yokosuka, Japan. Pabuk is currently moving to the northwest, but is expected to turn to the northeast.

The Joint Typhoon Warning Center forecast expects Pabuk to track parallel to the coast of Japan while now staying away from the big island. Pabuk is expected to become an extra-tropical cyclone in the next couple of days and gain frontal characteristics.

Please follow SpaceRef on Twitter and Like us on Facebook.

Go here to read the rest:

NASA Sees Typhoon Pabuk's Veiled Eye

Nano Labs Announces Promising Developments in Nanotechnology Gasoline

Posted on by

DETROIT, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (CTLE) is pleased to present the industry with promising test results relating to a proprietary nanotechnology which replaces commercial gasoline.

The Company has successfully tested their Nanotechnology Gasoline (NG). The technology combines 60% commercial grade gasoline with 40% ordinary drinking water plus the Company's proprietary nanotechnology. The result may mean an alternative to existing additives, like Ethanol, MTBE, Benzene, Methanol, and Aromatics additives that are harmful to the environment.

The Company has replaced 40% of gasoline with water and nanotechnology which thereby dramatically reduces the need of gasoline by over a third, thereby increasing fuel efficiency and reducing environmental emissions.

The Company reports that five gasoline mixtures were successfully tested; the tests were repeated three times over a period of thirteen months.

"Our new nano gasoline mixture combines our technology with normal tap water and gasoline which does not separate. In fact, it has remained intact after many months of testing. Also, the nano fuel does not freeze at temperatures of minus 40 degrees Celsius," states Dr. Victor Castano, Chief Innovations Officer of Nano Labs. "This is by far one of the most interesting projects our teams are working on right now, a game changer in the energy sector."

"This new technology would not require any changes to the existing refinery process and our nanotechnology could be applied directly at the fuel storage container stage," adds Mr. Bernardo Camacho Chavarria, President of Nano Labs. "This new technology could dramatically increase profits for the oil companies that they could pass on to consumers, and at the same time dramatically decrease the harmful emissions that contribute to global warming. It is important to note that we are at the development stage of the product, and are currently working with third-party labs for Octane and BTU Certification Testing. With these results we are looking to finalize a roadmap for commercialization and reporting back to industry and our shareholders."

About Nano Labs

Nano Labs Corp. (CTLE) is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit http://www.NanoLabs.us.

The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293

Forward looking statements

See more here:

Nano Labs Announces Promising Developments in Nanotechnology Gasoline

Global Nanotechnology and Nanomaterials Industry – 2013 Report

Posted on by

Dublin, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/822v4c/the_global) has announced the addition of the "The Global Nanotechnology and Nanomaterials Industry: Stage of Development, Global Activity and Market Opportunities" report to their offering.

Nanotechnology applications and nanomaterials are being applied across a raft of industries due to their outstanding magnetic, optical, catalytic and electronic properties. There are already established market for nanomaterials including titanium dioxide, zinc oxide, silicon oxide nanopowders and carbon nanotubes, nanofibers, nanosilver, nanoclays, quantum dots and nanoporous materials driven by demand from applications in filtration, electronics, cosmetics, energy, medicine, chemicals, coatings and catalysts. Recent breakthroughs have heralded new market opportunities in graphene and nanocellulose. This report provides a comprehensive insight into all aspects of the market for these materials.

WHAT DOES THE REPORT INCLUDE?

Key Topics Covered

1 EXECUTIVE SUMMARY

2 METHODOLOGY

3 NANOMATERIALS PRODUCTION: CURRENT AND PROJECTED

4 LICENSING AGREEMENTS/PARTNERSHIPS

5 REGULATIONS

6 PATENT ACTIVITY

The rest is here:

Global Nanotechnology and Nanomaterials Industry - 2013 Report

Persistent Organic Pollutants (POPs) Do Great Damage and BioEnergy Medicine – Video

Posted on by


Persistent Organic Pollutants (POPs) Do Great Damage and BioEnergy Medicine
POPs are relatively unknown and everyone is still concentrating on diet and exercise whereas the evidence now shows that POPs are fundamental to the obesity ...

By: gregory ellis

The rest is here:

Persistent Organic Pollutants (POPs) Do Great Damage and BioEnergy Medicine - Video

Flavell: Spring Seminar on Emergency Medicine 2013

Posted on by

SPEECH Wednesday 25th September 2013 Spring Seminar on Emergency Medicine 2013 Skyline Redwoods Forest venue Tuesday 24 September 2013; 7pm Te Ururoa Flavell; Co-leader of the Mori Party

I want to thank Peter Freeman and Annabel Jeffery for inviting me to address your conference as the Co-leader of the Mori Party and the local member of parliament for this area of Waiariki.

At first glance, I wondered what the intimate connection would be between the Mori Party the first indigenous party in Government throughout the world and the Peripheral Hospitals Emergency Medicine Conference; the Australasian Society for Emergency Medicine, and the Australasian Society of Career Medical Officers.

So I browsed through your programme for a clue.

As I read, the reason for my invitation became even more of a mystery.

Haematology; orthopaedic injuries; wound care and sepsis appeared to have more in common with the after-match care following the exploits of the Parliamentary Rugby team than an average day in the House.

Although there were a couple of other plenary sessions that I could relate to such as ethical issues; what was I thinking or even places you can go with your probe.

As I was about to give up, I re-read the riding instructions I had been given to help me in preparing my krero to you tonight.

And thats when I hit rock bottom.

I was told that the Horizon lecture will be an inspiring family event with a strong Maori flavour.

Read this article:

Flavell: Spring Seminar on Emergency Medicine 2013

ACT’s Dr. Robert Lanza to Receive the Il Leone di San Marco Award in Medicine

Posted on by

MARLBOROUGH, Mass.--(BUSINESS WIRE)--

Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that the companys Chief Scientific Officer, Robert Lanza, MD, has been nominated to receive the prestigious Il Leone di San Marco award in Medicine. For thirty-three years, the Italian Heritage and Culture Committee of the Bronx and Westchester has acknowledged outstanding Americans in fields such as the Performing Arts, Entertainment, Medicine, Journalism, Literature, Playwriting, Government, Science, Academia or Business. Past honorees have included Stanley Tucci, Paul Giamatti, Paul Sorvino, Danny Aiello, Armand Assante, Tony Danza, Susan Lucci, Dion DiMucci, Phil Ramone, Bart Giamatti, and Rudy Giuliani.

Dr. Lanza is one of only four people who will receive this years Il Leone di San Marco Award for their many talents and great accomplishments who represent the best in Italian-American culture. The other three honorees are Regis Philbin (Entertainment), Roma Torre (Theater Criticism), and Michael Gargiulo (Broadcast Journalism). The award in Medicine will be presented to Dr. Lanza on Sunday September 29th at the Davenport Club on Long Island Sound, New York. In addition to the award presentation, there will be musical performances by Giada Valenti, Eugene Ruffolo, and Luigi Moneta & Gayle Scott.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, the relevance and applicability of clinical trials in animals to studying the effect of products in humans, future growth in animal and human research and development programs, potential new applications of and expanded indications covering our technology, the effects of donorless sources of stem cells on potency and the risk of communicable diseases in the manufacturing context, the existence and size of potential or existing market opportunities for the company, the effect of the companys products on the medical needs and quality of life of pets, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words will, believes, plans, anticipates, expects, estimates, and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for and limited sources of future capital, failures or delays in obtaining regulatory approval of products, risks inherent in the development and commercialization of potential products, reliance on new and unproven technology in the development of products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the companys periodic reports, including the Quarterly Report on Form 10-Q for the three months ended June 30, 2013. Forward-looking statements are based on the beliefs, opinions, and expectations of the companys management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the companys management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. There can be no assurance that the Companys clinical trials will be successful.

See the article here:

ACT’s Dr. Robert Lanza to Receive the Il Leone di San Marco Award in Medicine